MacroGenics, Inc. - Common Stock (NQ:MGNX)

3.745 +0.165 (+4.61%)

Delayed Quote Updated: 2:12 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Shareholder Rights Law Firm Robbins LLP Urges MGNX Stockholders to Contact the Firm for More Information About the MacroGenics, Inc. Class Action

August 12, 2024

From Robbins LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DXC, CrowdStrike, MacroGenics, and Five Below and Encourages Investors to Contact the Firm

August 12, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline

August 12, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

August 11, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

ROSEN, A LEADING NATIONAL FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNX

August 09, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Kirby McInerney LLP Reminds MacroGenics, Inc. (MGNX) Investors of Class Action Filing and Encourages Investors to Contact the Firm

August 07, 2024

From Kirby McInerney LLP

Via GlobeNewswire

MacroGenics, Inc. Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against MGNX

August 07, 2024

From Robbins LLP

Via GlobeNewswire

MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

August 07, 2024

From Schall Law

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vicor, American Airlines, and MacroGenics and Encourages Investors to Contact the Firm

August 06, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNX

August 06, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline

August 05, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

MGNX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

August 04, 2024

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNX

August 03, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vicor and MacroGenics and Encourages Investors to Contact the Firm

August 02, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

August 02, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MacroGenics, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the MGNX Class Action

August 02, 2024

From Robbins LLP

Via Business Wire

NASDAQ:MGNX: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against MacroGenics, Inc.

July 31, 2024

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

After Reporting Five Patient Deaths, Data Committee Recommends MacroGenics Halt Prostate Cancer Trial ↗

July 31, 2024

MacroGenics will discontinue vobra duo for remaining mCRPC participants after five deaths. New data to be presented at ESMO 2024 conference.

Via Benzinga

Topics Death

MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 31, 2024

From Schall Law

Via GlobeNewswire

Match Group Layoffs 2024: What to Know About the Latest MTCH Job Cuts ↗

July 31, 2024

Match Group layoffs are a hot topic on Wednesday as the dating website operator is preparing to reduce its headcount due to demand changes.

Via InvestorPlace

Topics Workforce

Why is Macrogenics (MGNX) Stock Down 28% Today? ↗

July 31, 2024

Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial.

Via InvestorPlace

Pinterest Issues Weak Revenue Forecast, Joins Groupon, O-I Glass And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

July 31, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 31, 2024

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!

Via InvestorPlace

Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

July 31, 2024

Via Benzinga

Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against MacroGenics, Inc. (MGNX)

July 30, 2024

From Robbins LLP

Via GlobeNewswire

MACROGENICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. and Encourages Investors to Contact the Firm

July 30, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

MACROGENICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against MacroGenics, Inc. - MGNX

July 30, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

MacroGenics Provides Vobramitamab Duocarmazine Update

July 30, 2024

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte

July 30, 2024

Confirming cash runway guidance into 2026

From MacroGenics, Inc.

Via GlobeNewswire

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of MacroGenics, Inc. (MGNX) Investors

July 30, 2024

From Kirby McInerney LLP

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.